American Healthcare REIT (NYSE:AHR) Price Target Raised to $30.00

American Healthcare REIT (NYSE:AHR) had its price objective lifted by JMP Securities from $18.00 to $30.00 in a report released on Friday, Benzinga reports. They currently have a market outperform rating on the stock.

Several other analysts also recently commented on AHR. Bank of America increased their price objective on American Healthcare REIT from $19.00 to $27.00 and gave the stock a buy rating in a research note on Tuesday, August 20th. Morgan Stanley increased their price target on American Healthcare REIT from $17.00 to $22.00 and gave the company an overweight rating in a research report on Thursday, August 22nd. Truist Financial increased their price target on American Healthcare REIT from $17.00 to $22.00 and gave the company a buy rating in a research report on Tuesday, September 3rd. Finally, KeyCorp increased their price target on American Healthcare REIT from $16.00 to $27.00 and gave the company an overweight rating in a research report on Monday, September 16th. One research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, American Healthcare REIT presently has an average rating of Moderate Buy and an average price target of $22.50.

American Healthcare REIT Stock Performance

Shares of AHR stock opened at $25.68 on Friday. The stock’s fifty day simple moving average is $19.44 and its 200 day simple moving average is $16.08. American Healthcare REIT has a twelve month low of $12.63 and a twelve month high of $26.32. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.29 and a current ratio of 0.29.

American Healthcare REIT (NYSE:AHR) last announced its earnings results on Monday, August 5th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.28). American Healthcare REIT had a negative net margin of 1.99% and a negative return on equity of 2.20%. The business had revenue of $504.60 million for the quarter, compared to the consensus estimate of $506.55 million. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. On average, sell-side analysts predict that American Healthcare REIT will post 1.28 earnings per share for the current fiscal year.

American Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 18th. Stockholders of record on Friday, September 20th will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.89%. The ex-dividend date is Friday, September 20th.

Hedge Funds Weigh In On American Healthcare REIT

Large investors have recently made changes to their positions in the stock. Kiely Wealth Advisory Group Inc. bought a new position in shares of American Healthcare REIT in the second quarter worth $30,000. Amalgamated Bank bought a new stake in American Healthcare REIT during the second quarter valued at $33,000. Semmax Financial Advisors Inc. bought a new stake in American Healthcare REIT during the second quarter valued at $45,000. CWM LLC bought a new stake in American Healthcare REIT during the second quarter valued at $58,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in American Healthcare REIT during the second quarter valued at $110,000. 16.68% of the stock is owned by institutional investors.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.